Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-20 09:37 am Sale | 2026-06-30 | 13G | UNIQURE N V QURE | Aberdeen Group plc | 2,848,117 4.520% | -2,458,269 (-46.33%) | Filing History |
| 2026-07-20 07:08 am Sale | 2026-06-30 | 13G | CODEXIS INC CDXS | Aberdeen Group plc | 6,769,954 7.450% | -1,196,544 (-15.02%) | Filing History |
| 2026-07-16 06:15 am Sale | 2026-06-30 | 13G | IMMUNIC INC IMUX | Aberdeen Group plc | 824,393 6.050% | -1 (-0.00%) | Filing History |
| 2026-07-15 10:27 am Purchase | 2026-06-30 | 13G | SERA PROGNOSTICS INC SERA | Aberdeen Group plc | 2,753,525 7.210% | 526,158 (+23.62%) | Filing History |
| 2026-05-07 11:09 am Purchase | 2026-04-01 | 13G | EQUILLIUM INC EQ | Aberdeen Group plc | 3,352,837 5.300% | 3,352,837 (New Position) | Filing History |
| 2026-04-30 08:21 am Purchase | 2026-04-01 | 13G | UNIQURE N V QURE | Aberdeen Group plc | 5,306,386 8.490% | 1,627,746 (+44.25%) | Filing History |
| 2026-04-29 06:41 am Unchanged | 2026-04-01 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Aberdeen Group plc | 75,000 4.160% | 0 (Unchanged) | Filing History |
| 2026-04-28 09:38 am Purchase | 2026-04-01 | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | Aberdeen Group plc | 578,565 6.490% | 578,565 (New Position) | Filing History |
| 2026-02-02 10:35 am Purchase | 2025-12-31 | 13G | INSPIREMD INC NSPR | Aberdeen Group plc | 3,173,364 7.490% | 692,247 (+27.90%) | Filing History |
| 2026-02-02 10:31 am Unchanged | 2025-12-31 | 13G | IMMUNIC INC IMUX | Aberdeen Group plc | 824,394 6.850% | 0 (Unchanged) | Filing History |
| 2026-01-29 3:15 pm Purchase | 2025-12-31 | 13G | UNIQURE N V QURE | Aberdeen Group plc | 3,678,640 5.910% | 738,897 (+25.13%) | Filing History |
| 2026-01-29 3:15 pm Purchase | 2025-12-31 | 13G | TECTONIC THERAPEUTIC INC TECX | Aberdeen Group plc | 1,141,824 6.100% | 1,141,824 (New Position) | Filing History |
| 2026-01-28 11:05 am Purchase | 2025-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Aberdeen Group plc | 75,000 8.940% | 75,000 (New Position) | Filing History |
| 2026-01-27 10:10 am Purchase | 2025-12-31 | 13G | PRECISION BIOSCIENCES INC DTIL | Aberdeen Group plc | 2,138,603 8.880% | 2,138,603 (New Position) | Filing History |
| 2026-01-16 09:59 am Purchase | 2025-12-31 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Aberdeen Group plc | 1,321,750 7.530% | 1,321,750 (New Position) | Filing History |
| 2026-01-15 1:42 pm Purchase | 2025-12-31 | 13G | CODEXIS INC CDXS | Aberdeen Group plc | 7,966,498 8.820% | 3,874,436 (+94.68%) | Filing History |
| 2025-11-07 11:28 am Sale | 2025-10-01 | 13G | CODEXIS INC CDXS | Aberdeen Group plc | 4,092,062 4.530% | -108,888 (-2.59%) | Filing History |
| 2025-11-07 06:25 am Purchase | 2025-10-01 | 13G | INSPIREMD INC NSPR | Aberdeen Group plc | 2,481,117 5.950% | 2,481,117 (New Position) | Filing History |
| 2025-10-14 2:41 pm Purchase | 2025-09-30 | 13G | UNIQURE N V QURE | Aberdeen Group plc | 2,939,743 4.770% | 189,029 (+6.87%) | Filing History |
| 2025-08-05 10:22 am Purchase | 2025-06-30 | 13G | SERA PROGNOSTICS INC SERA | Aberdeen Group plc | 2,227,367 6.070% | 2,227,367 (New Position) | Filing History |